If you have been reading about certificate of analysis and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-24. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
The human body's immune response to a surgically installed foreign object—breast implant, cardiac pacemaker, orthopedic prosthesis—is to encapsulate it with scar tissue capsules of tightly woven collagen fibers, in order to maintain the integrity of the body by isolating the foreign object, and so tolerate its presence. Capsular contracture—which should be distinguished from normal capsular tissue—occurs when the collagen-fiber capsule thickens and compresses the breast implant; it is a painful complication that might distort either the breast implant, or the breast, or both. Capsular contracture is diagnosed through a visual and physical examiniation according to level of increasing severity based on the Baker Grade scale: Baker Grade I, Baker Grade II, Baker Grade III, and Baker Grade IV.
However, Ioseliani died of a heart attack in March 2003. When the Mkhedrioni failed to secure registration to stand in elections under its own name, it reconstituted itself in November 2002 as a political party called the Union of Patriots in alliance with former Gamsakhurdia supporters. It was again refused registration by the government. Its leader Badri Zarandia was assassinated on January 8, 2003.
=== Treatment after exposure === The primary treatment is removal of the offending substance. Capsaicin is soluble in alcohol, which can be used to clean contaminated items. Plain water is ineffective at removing capsaicin in most situations, but flushing continuously with water may be used when no alternative is available, such as when treating the eyes or skin. When capsaicin is ingested, cold milk may be an effective way to relieve the burning sensation due to caseins in milk, and the water of milk acts as a surfactant, allowing the capsaicin to form an emulsion with it.
Sources: en.wikipedia.org
=== Public security === The Federal Government presented a proposed constitutional amendment (PEC) aimed at modernizing and integrating public security in the country. The initiative, led by the ministry of justice and public security, Ricardo Lewandowski, seeks to strengthen the fight against organized crime and improve cooperation among the Union, states and municipalities. Among the main points are the creation of a Unified Public Security System (SUSP) with constitutional status, the expansion of the responsibilities of the Federal Police and the Federal Highway Police – which would be renamed the Federal Ostensive Police – and the consolidation of permanent financial instruments, such as the National Public Security and Penitentiary Policy Fund, guaranteeing stable resources for the sector. The government argues that the proposal does not remove the autonomy of the states, but seeks to promote greater coordination and efficiency in police action, especially in the face of the advance of criminal factions operating beyond state borders. Even so, the text faces resistance from sectors of the right and the opposition. Despite the criticism, the Ministry of Justice states that the proposal was built in dialogue with governors and specialists, and that it represents an effort to make the fight against crime more integrated, technological and effective throughout the national territory.
== Transcript variants == Transcription of C3orf62 produces 5 alternatively spliced variants and 1 unspliced form. Of the four splice variants, two of them are protein coding, one is nonsense meditated decay, and one is a retained intron. QIAGEN denotes the following as transcription factor binding sites in the C3orf62 promoter: TFCP2, Pax-6, p53, MyoD, YY1, Ik-2, AREB6, IRF-7A3.
However, in spent nuclear fuel that does not quickly undergo nuclear reprocessing but instead is cooled for years after use, much or most of the 241Pu will beta decay to americium-241, one of the minor actinides, a strong alpha emitter, and difficult to use in thermal reactors. 242Pu has a particularly low cross section for thermal neutron capture; and it takes three neutron absorptions to become another fissile isotope (either curium-245 or 241Pu) and fission. Even then, there is a chance either of those two fissile isotopes will fail to fission but instead absorb a fourth neutron, becoming curium-246 (on the way to even heavier actinides like californium, which is a neutron emitter by spontaneous fission and difficult to handle) or becoming 242Pu again; so the mean number of neutrons absorbed before fission is even higher than 3. Therefore, 242Pu is particularly unsuited to recycling in a thermal reactor and would be better used in a fast reactor where it can be fissioned directly. However, 242Pu's low cross section means that relatively little of it will be transmuted during one cycle in a thermal reactor. 242Pu's half-life is about 15 times as long as 239Pu's half-life; therefore, it is 1/15 as radioactive and not one of the larger contributors to nuclear waste radioactivity. 242Pu's gamma ray emissions are also weaker than those of the other isotopes. 243Pu has a half-life of only 5 hours, beta decaying to americium-243.
Sources: en.wikipedia.org
=== Nuclear magnetic resonance spectroscopy === In NMR spectroscopy, e.g. of the nuclei 1H, 13C and 29Si, frequencies depend on the magnetic field, which is not the same across all experiments. Therefore, frequencies are reported as relative differences to tetramethylsilane (TMS), an internal standard that George Tiers proposed in 1958 and that the International Union of Pure and Applied Chemistry has since endorsed. The relative difference to TMS is called chemical shift. TMS works as an ideal standard because it is relatively inert and its identical methyl protons produce a strong upfield signal, isolated from most other protons. It is soluble in most organic solvents and is removable via distillation due to its low boiling point. In practice, the difference between the signals of common solvents and TMS are known. Therefore, no TMS needs to be added to commercial deuterated solvents, as modern instruments are capable of detecting the small quantities of protonated solvent present. By specifying the lock solvent to be used, modern spectrometers are able to correctly reference the sample; in effect, the solvent itself serves as the internal standard.
=== Nerves === The reptilian nervous system contains the same basic part of the amphibian brain, but the reptile cerebrum and cerebellum are slightly larger. Most typical sense organs are well developed with certain exceptions, most notably the snake's lack of external ears (middle and inner ears are present). There are twelve pairs of cranial nerves. Due to their short cochlea, reptiles use electrical tuning to expand their range of audible frequencies.
=== SNPs === Among the different genetic variants identified so far, several single nucleotide variants have been associated with diseases. The vast majority of single nucleotide variants in LNPEP are intronic variants that are part of an extended haplotype that functions as a transcriptional enhancer of the adjacent gene ERAP2 but does not regulate LNPEP expression. In fact, compared to its M1- aminopeptidase family members ERAP1 and ERAP2, LNPEP shows low tolerance to protein-truncating genetic variation and contains few loss-of-function variants in its gene.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.